Literature DB >> 25301692

Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system.

Beth Chaplin1, Seema Meloni1, Geoffrey Eisen1, Toyin Jolayemi2, Bolanle Banigbe2, Juliette Adeola2, Craig Wen1, Harry Reyes Nieva1, Charlotte Chang1, Prosper Okonkwo2, Phyllis Kanki3.   

Abstract

OBJECTIVES: The implementation of PEPFAR programs in resource-limited settings was accompanied by the need to document patient care on a scale unprecedented in environments where paper-based records were the norm. We describe the development of an electronic medical records system (EMRS) put in place at the beginning of a large HIV/AIDS care and treatment program in Nigeria.
METHODS: Databases were created to record laboratory results, medications prescribed and dispensed, and clinical assessments, using a relational database program. A collection of stand-alone files recorded different elements of patient care, linked together by utilities that aggregated data on national standard indicators and assessed patient care for quality improvement, tracked patients requiring follow-up, generated counts of ART regimens dispensed, and provided 'snapshots' of a patient's response to treatment. A secure server was used to store patient files for backup and transfer.
RESULTS: By February 2012, when the program transitioned to local in-country management by APIN, the EMRS was used in 33 hospitals across the country, with 4,947,433 adult, pediatric and PMTCT records that had been created and continued to be available for use in patient care. Ongoing trainings for data managers, along with an iterative process of implementing changes to the databases and forms based on user feedback, were needed. As the program scaled up and the volume of laboratory tests increased, results were produced in a digital format, wherever possible, that could be automatically transferred to the EMRS. Many larger clinics began to link some or all of the databases to local area networks, making them available to a larger group of staff members, or providing the ability to enter information simultaneously where needed.
CONCLUSIONS: The EMRS improved patient care, enabled efficient reporting to the Government of Nigeria and to U.S. funding agencies, and allowed program managers and staff to conduct quality control audits.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Africa; Continuity of patient care; Electronic medical records; HIV therapy; Nigeria; User–computer interface

Mesh:

Year:  2014        PMID: 25301692     DOI: 10.1016/j.ijmedinf.2014.09.006

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  18 in total

1.  Scaling-up health information systems to improve HIV treatment: An assessment of initial patient monitoring systems in Mozambique.

Authors:  Mindy Hochgesang; Sophia Zamudio-Haas; Lissa Moran; Leopoldo Nhampossa; Laura Packel; Hannah Leslie; Janise Richards; Starley B Shade
Journal:  Int J Med Inform       Date:  2016-11-10       Impact factor: 4.046

Review 2.  Health Worker mHealth Utilization: A Systematic Review.

Authors:  Alice White; Deborah S K Thomas; Nnamdi Ezeanochie; Sheana Bull
Journal:  Comput Inform Nurs       Date:  2016-05       Impact factor: 1.985

Review 3.  ART uptake and adherence among female sex workers (FSW) globally: A scoping review.

Authors:  Jennifer L Glick; Rienna G Russo; Aimee Kao-Hsuan Huang; Belinda Jivapong; Vijayasundaram Ramasamy; Lori M Rosman; Danielle L Pelaez; Susan G Sherman
Journal:  Glob Public Health       Date:  2020-12-10

4.  Knowledge of electronic medical records system among frontline health care workers in Jos University teaching hospital, Plateau State Nigeria.

Authors:  Tolulope O Afolaranmi; Zuwaira I Hassan; Bulus L Dawar; Bamkat D Wilson; Abdulbasit I Zakari; Kayode K Bello; Akinyemi O D Ofakunrin; Gabriel O Ogbeyi
Journal:  Int J Res Med Sci       Date:  2020-10-30

Review 5.  Why sub-Saharan Africa lags in electronic health record adoption and possible strategies to increase its adoption in this region.

Authors:  Florence Femi Odekunle; Raphael Oluseun Odekunle; Srinivasan Shankar
Journal:  Int J Health Sci (Qassim)       Date:  2017 Sep-Oct

6.  Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.

Authors:  Seema T Meloni; Chika K Onwuamah; Oche Agbaji; Beth Chaplin; David O Olaleye; Rosemary Audu; Jay Samuels; Oliver Ezechi; Godwin Imade; Adesola Z Musa; Georgina Odaibo; Jonathan Okpokwu; Holly Rawizza; Muhammad A Mu'azu; Ibrahim Dalhatu; Mukhtar Ahmed; Prosper Okonkwo; Elliot Raizes; Innocent A O Ujah; Chunfu Yang; Emmanuel O Idigbe; Phyllis J Kanki
Journal:  Open Forum Infect Dis       Date:  2017-11-02       Impact factor: 3.835

7.  Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria.

Authors:  Patricia A Agaba; Seema T Meloni; Halima M Sule; Oche O Agbaji; Atiene S Sagay; Prosper Okonkwo; John A Idoko; Phyllis J Kanki
Journal:  Open Forum Infect Dis       Date:  2017-02-12       Impact factor: 3.835

8.  Factors associated with early menopause among women in Nigeria.

Authors:  Patricia Agaba; Seema Meloni; Halima Sule; Amaka Ocheke; Emmanuel Agaba; John Idoko; Phyllis Kanki
Journal:  J Virus Erad       Date:  2017-07-01

9.  Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria.

Authors:  Charlotte A Chang; Seema Thakore Meloni; Geoffrey Eisen; Beth Chaplin; Patrick Akande; Prosper Okonkwo; Holly E Rawizza; Eric Tchetgen Tchetgen; Phyllis J Kanki
Journal:  Open Forum Infect Dis       Date:  2015-10-17       Impact factor: 3.835

10.  Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.

Authors:  Kimberly K Scarsi; Geoffrey Eisen; Kristin M Darin; Seema T Meloni; Holly E Rawizza; Eric J Tchetgen Tchetgen; Oche O Agbaji; Daniel I Onwujekwe; Wadzani Gashau; Reuben Nkado; Prosper Okonkwo; Robert L Murphy; Phyllis J Kanki
Journal:  Clin Infect Dis       Date:  2015-11-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.